Related Experiment Video
Updated: Jul 20, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Advances in cardiac intensive care
David S Cooper1, Mark A Nichter
1The Congenital Heart Institute of Florida, Cardiac Intensive Care Unit, All Children's Hospital, University of South Florida, St Petersburg, FL 33701, USA. davidscooper@verizon.net
Insights
Improving surgical survival in children with congenital heart disease necessitates reducing intensive care unit (ICU) morbidities. Emerging therapies aim to minimize complications like fluid overload and renal dysfunction, enhancing recovery after pediatric cardiac surgery.
Area of Science:
- Pediatric Cardiology
- Critical Care Medicine
- Congenital Heart Surgery
Background:
- Improved surgical survival for children with congenital heart disease (CHD), especially univentricular hearts, has shifted focus to reducing treatment-related morbidity.
- Protracted intensive care unit (ICU) stays post-cardiac surgery are linked to increased morbidity, highlighting the need for faster recovery interventions.
Purpose of the Study:
- To review emerging therapies for reducing morbidity in the ICU for pediatric patients with congenital cardiac malformations.
- To identify interventions that hasten postoperative recovery and minimize ICU length of stay.
Main Methods:
- Literature review focusing on recent advancements in critical care for pediatric cardiac surgery patients.
- Analysis of therapies targeting common morbidities such as fluid overload, renal dysfunction, low cardiac output, and neurological dysfunction.
Main Results:
- Fluid overload, renal dysfunction, low cardiac output, and neurological dysfunction are key contributors to morbidity after pediatric cardiac surgery.
- Interventions that expedite recovery and reduce ICU stay are crucial for mitigating these adverse outcomes.
- The treatment of these complications can sometimes exacerbate the initial injury.
Conclusions:
- Reducing morbidity after pediatric cardiac surgery remains a significant challenge.
- Factors beyond the intraoperative period critically impact patient outcomes.
- Future research should explore novel technologies and therapies to prevent physiological states that worsen congenital morbidities.
Purpose Of Review:
As surgical survival in children with congenital heart disease, particularly those with univentricular hearts, has improved in recent years, focus has shifted to reducing the morbidity of congenital cardiac malformations and their treatment. This review will focus on emerging therapies aimed at reducing these morbidities in the intensive care unit.
Recent Findings:
A protracted stay in the intensive care unit after cardiac surgery is a risk factor for developing various morbidities. Therapies or interventions that may hasten postoperative recovery and minimize the length of stay are thus important to evaluate. Fluid overload, renal dysfunction, low cardiac output and neurological dysfunction remain major contributors to morbidity after cardiac surgery. In addition, the treatment of these adverse states can potentially compound the injury.
Summary:
The reduction in morbidity after cardiac surgery remains challenging. Recent insights have allowed us to recognize the impact of factors beyond the intraoperative period as significant contributors to morbidity. As our field continues to evolve, future studies should focus on emerging technologies and therapies that facilitate the prevention of physiological states that compound congenital morbidities.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Introduction Cardiac Emergencies
Heart Failure VI: Adjunct Therapies
Cardiac Catheterization I: Pre-Procedure Overview
